Oncology Institute Inc
TOIIW0.130USD
+0.010+7.97%
Close （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Oncology Institute Inc Company
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Oncology Institute Inc Info
Ticker SymbolTOIIW
Company nameOncology Institute Inc
IPO dateMar 13, 2020
CEODr. Daniel Virnich, M.D.
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address18000 Studebaker Rd
CityCERRITOS
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code90703
Phone15627353226
Websitehttps://theoncologyinstitute.com/
Ticker SymbolTOIIW
IPO dateMar 13, 2020
CEODr. Daniel Virnich, M.D.
Company Executives of Oncology Institute Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
--
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
--
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
23
3.99M
0.00%
-440.40K
2025Q3
22
3.81M
0.00%
-545.03K
2025Q2
23
3.64M
0.00%
-841.05K
2025Q1
23
3.52M
0.00%
-962.71K
2024Q4
23
3.58M
0.00%
+202.91K
2024Q3
25
2.60M
0.00%
-2.54M
2024Q2
25
4.25M
0.00%
-750.47K
2024Q1
23
4.12M
0.00%
-845.27K
2023Q4
23
4.49M
0.00%
-323.33K
2023Q3
21
4.44M
0.00%
-229.36K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
LMR Partners LLP
1.62M
0%
--
--
Sep 30, 2025
Deerfield Management Company, L.P.
1.25M
0%
--
--
Sep 30, 2025
Davidson Kempner Capital Management LP
318.71K
0%
--
--
Sep 30, 2025
Healthcare Of Ontario Pension Plan
87.50K
0%
--
--
Sep 30, 2025
GLG LLC
85.85K
0%
--
--
Sep 30, 2025
Wolverine Asset Management, LLC
197.02K
0%
+5.45K
+2.85%
Sep 30, 2025
Alpine Global Management, LLC
25.02K
0%
--
--
Sep 30, 2025
Tenor Capital Management Co., L.P.
25.00K
0%
--
--
Sep 30, 2025
Citadel Advisors LLC
--
0%
-12.38K
-100.00%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Oncology Institute Inc?
The top five shareholders of Oncology Institute Inc are:
LMR Partners LLP holds 1.62M shares, accounting for 0.00% of the total shares.
Deerfield Management Company, L.P. holds 1.25M shares, accounting for 0.00% of the total shares.
Davidson Kempner Capital Management LP holds 318.71K shares, accounting for 0.00% of the total shares.
Healthcare Of Ontario Pension Plan holds 87.50K shares, accounting for 0.00% of the total shares.
GLG LLC holds 85.85K shares, accounting for 0.00% of the total shares.
LMR Partners LLP holds 1.62M shares, accounting for 0.00% of the total shares.
Deerfield Management Company, L.P. holds 1.25M shares, accounting for 0.00% of the total shares.
Davidson Kempner Capital Management LP holds 318.71K shares, accounting for 0.00% of the total shares.
Healthcare Of Ontario Pension Plan holds 87.50K shares, accounting for 0.00% of the total shares.
GLG LLC holds 85.85K shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of Oncology Institute Inc?
The top three shareholder types of Oncology Institute Inc are:
Other
Other
How many institutions hold shares of Oncology Institute Inc (TOIIW)?
As of 2025Q4, 23 institutions hold shares of Oncology Institute Inc, with a combined market value of approximately 3.99M, accounting for --% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Oncology Institute Inc?
In --, the -- business generated the highest revenue for Oncology Institute Inc, amounting to -- and accounting for --% of total revenue.
